## Prophylactic Antibiotic in Sickle Cell Disease **Key Point:** Penicillin V is the first-line prophylactic agent against encapsulated organisms (especially *Streptococcus pneumoniae*) in sickle cell patients, particularly children <5 years. ### Rationale for Penicillin Prophylaxis **High-Yield:** Sickle cell patients have functional asplenia due to: 1. Repeated splenic infarction from vaso-occlusion 2. Loss of opsonizing antibodies and complement-mediated immunity 3. Impaired clearance of encapsulated bacteria This results in a 300–400-fold increased risk of invasive pneumococcal disease. ### Penicillin V Dosing & Duration | Age Group | Dose | Route | Duration | |---|---|---|---| | <5 years | 125 mg BID | PO | Until age 5 years (minimum) | | ≥5 years | 250 mg BID | PO | Lifelong or until splenectomy | | Penicillin-allergic | Erythromycin 250 mg BID | PO | Same duration | **Clinical Pearl:** Penicillin prophylaxis is recommended from diagnosis (or age 2 months) and continued lifelong in most patients. Compliance is critical — missed doses increase infection risk. ### Vaccination Adjunct Penicillin prophylaxis is NOT a substitute for: - Pneumococcal conjugate vaccine (PCV13) at 2, 4, 6, 12–15 months - Pneumococcal polysaccharide vaccine (PPSV23) at ≥2 years - Annual influenza vaccine - Meningococcal vaccine **Warning:** Do NOT discontinue penicillin even after vaccination — prophylaxis must continue because vaccine response is suboptimal in asplenic patients. ### Why Penicillin V (Not Amoxicillin) - Penicillin V is acid-stable and reliably absorbed orally - Amoxicillin has similar coverage but penicillin V is the traditional choice in pediatric sickle cell guidelines - Both are acceptable; penicillin V is preferred by convention [cite:Harrison 21e Ch 104; Park 26e Ch 18]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.